Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2012

Open Access 01-12-2012 | Study protocol

A nationwide study on reproductive function, ovarian reserve, and risk of premature menopause in female survivors of childhood cancer: design and methodological challenges

Authors: Annelies Overbeek, Marleen H van den Berg, Leontien CM Kremer, Marry M van den Heuvel-Eibrink, Wim JE Tissing, Jacqueline J Loonen, Birgitta Versluys, Dorine Bresters, Gertjan JL Kaspers, Cornelis B Lambalk, Flora E van Leeuwen, Eline van Dulmen-den Broeder

Published in: BMC Cancer | Issue 1/2012

Login to get access

Abstract

Background

Advances in childhood cancer treatment over the past decades have significantly improved survival, resulting in a rapidly growing group of survivors. However, both chemo- and radiotherapy may adversely affect reproductive function. This paper describes the design and encountered methodological challenges of a nationwide study in the Netherlands investigating the effects of treatment on reproductive function, ovarian reserve, premature menopause and pregnancy outcomes in female childhood cancer survivors (CCS), the DCOG LATER-VEVO study.

Methods

The study is a retrospective cohort study consisting of two parts: a questionnaire assessing medical, menstrual, and obstetric history, and a clinical assessment evaluating ovarian and uterine function by hormonal analyses and transvaginal ultrasound measurements. The eligible study population consists of adult female 5-year survivors of childhood cancer treated in the Netherlands, whereas the control group consists of age-matched sisters of the participating CCS. To date, study invitations have been sent to 1611 CCS and 429 sister controls, of which 1215 (75%) and 333 (78%) have responded so far. Of these responders, the majority consented to participate in both parts of the study (53% vs. 65% for CCS and sister controls respectively). Several challenges were encountered involving the study population: dealing with bias due to the differences in characteristics of several types of (non-) participants and finding an adequately sized and well-matched control group. Moreover, the challenges related to the data collection process included: differences in response rates between web-based and paper-based questionnaires, validity of self-reported outcomes, interpretation of clinical measurements of women using hormonal contraceptives, and inter- and intra-observer variation of the ultrasound measurements.

Discussion

The DCOG LATER-VEVO study will provide valuable information about the reproductive potential of paediatric cancer patients as well as long-term survivors of childhood cancer. Other investigators planning to conduct large cohort studies on late effects may encounter similar challenges as those encountered during this study. The solutions to these challenges described in this paper may be useful to these investigators.
Appendix
Available only for authorised users
Literature
1.
Chemaitilly W, Mertens AC, Mitby P, Whitton J, Stovall M, Yasui Y, Robison LL, Sklar CA: Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab. 2006, 91: 1723-1728. 10.1210/jc.2006-0020.CrossRefPubMed
2.
Green DM, Sklar CA, Boice JD, Mulvihill JJ, Whitton JA, Stovall M, Yasui Y: Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study. J Clin Oncol. 2009, 27: 2374-2381. 10.1200/JCO.2008.21.1839.CrossRefPubMedPubMedCentral
3.
Madanat-Harjuoja LM, Malila N, Lahteenmaki PM, Boice JD, Gissler M, Dyba T: Preterm delivery among female survivors of childhood, adolescent and young adulthood cancer. Int J Cancer. 2010, 127: 1669-1679. 10.1002/ijc.25157.CrossRefPubMedPubMedCentral
4.
Reulen RC, Zeegers MP, Wallace WH, Frobisher C, Taylor AJ, Lancashire ER, Winter DL, Hawkins MM: Pregnancy outcomes among adult survivors of childhood cancer in the British Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev. 2009, 18: 2239-2247. 10.1158/1055-9965.EPI-09-0287.CrossRefPubMedPubMedCentral
5.
Signorello LB, Mulvihill JJ, Green DM, Munro HM, Stovall M, Weathers RE, Mertens AC, Whitton JA, Robison LL, Boice JD: Stillbirth and neonatal death in relation to radiation exposure before conception: a retrospective cohort study. Lancet. 2010, 376: 624-630. 10.1016/S0140-6736(10)60752-0.CrossRefPubMedPubMedCentral
6.
Sklar CA, Mertens AC, Mitby P, Whitton J, Stovall M, Kasper C, Mulder J, Green D, Nicholson HS, Yasui Y, Robison LL: Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst. 2006, 98: 890-896. 10.1093/jnci/djj243.CrossRefPubMed
7.
van Beek RD, van den Heuvel-Eibrink MM, Laven JS, de Jong FH, Themmen AP, Hakvoort-Cammel FG, van den Bos C, van den Berg H, Pieters R, de Muinck Keizer-Schrama SM: Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood. J Clin Endocrinol Metab. 2007, 92: 3869-3874. 10.1210/jc.2006-2374.CrossRefPubMed
8.
Lie FS, van den Heuvel-Eibrink MM, Eijkemans MJ, Schipper I, Hukkelhoven CW, Laven JS: Pregnancy outcome in female childhood cancer survivors. Hum Reprod. 2010, 25: 1206-1212. 10.1093/humrep/deq029.CrossRef
9.
van Dorp W, van Beek RD, Laven JS, Pieters R, de Muinck Keizer-Schrama SM, van den Heuvel-Eibrink MM: Long-term endocrine side effects of childhood Hodgkin's lymphoma treatment: a review. Hum Reprod Update. 2012, 18: 12-28. 10.1093/humupd/dmr038.CrossRefPubMed
10.
Armstrong GT, Whitton JA, Gajjar A, Kun LE, Chow EJ, Stovall M, Leisenring W, Robison LL, Sklar CA: Abnormal timing of menarche in survivors of central nervous system tumors: A report from the Childhood Cancer Survivor Study. Cancer. 2009, 115: 2562-2570. 10.1002/cncr.24294.CrossRefPubMedPubMedCentral
11.
Byrne J, Fears TR, Gail MH, Pee D, Connelly RR, Austin DF, Holmes GF, Holmes FF, Latourette HB, Meigs JW: Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol. 1992, 166: 788-793.CrossRefPubMed
12.
Chiarelli AM, Marrett LD, Darlington G: Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964–1988 in Ontario, Canada. Am J Epidemiol. 1999, 150: 245-254. 10.1093/oxfordjournals.aje.a009995.CrossRefPubMed
13.
Green DM, Whitton JA, Stovall M, Mertens AC, Donaldson SS, Ruymann FB, Pendergrass TW, Robison LL: Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Am J Obstet Gynecol. 2002, 187: 1070-1080. 10.1067/mob.2002.126643.CrossRefPubMed
14.
Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, Mertens AC, Donaldson SS, Byrne J, Robison LL: Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2009, 27: 2677-2685. 10.1200/JCO.2008.20.1541.CrossRefPubMedPubMedCentral
15.
Magelssen H, Melve KK, Skjaerven R, Fossa SD: Parenthood probability and pregnancy outcome in patients with a cancer diagnosis during adolescence and young adulthood. Hum Reprod. 2008, 23: 178-186.CrossRefPubMed
16.
Mueller BA, Chow EJ, Kamineni A, Daling JR, Fraser A, Wiggins CL, Mineau GP, Hamre MR, Severson RK, Drews-Botsch C: Pregnancy outcomes in female childhood and adolescent cancer survivors: a linked cancer-birth registry analysis. Arch Pediatr Adolesc Med. 2009, 163: 879-886. 10.1001/archpediatrics.2009.112.CrossRefPubMedPubMedCentral
17.
Reinmuth S, Liebeskind AK, Wickmann L, Bockelbrink A, Keil T, Henze G, Borgmann A: Having children after surviving cancer in childhood or adolescence - results of a Berlin survey. Klin Padiatr. 2008, 220: 159-165. 10.1055/s-2008-1073143.CrossRefPubMed
18.
Sudour H, Chastagner P, Claude L, Desandes E, Klein M, Carrie C, Bernier V: Fertility and pregnancy outcome after abdominal irradiation that included or excluded the pelvis in childhood tumor survivors. Int J Radiat Oncol Biol Phys. 2010, 76: 867-873. 10.1016/j.ijrobp.2009.04.012.CrossRefPubMed
19.
Winther JF, Boice JD, Svendsen AL, Frederiksen K, Stovall M, Olsen JH: Spontaneous abortion in a Danish population-based cohort of childhood cancer survivors. J.Clin.Oncol. 2008, 26: 4340-4346. 10.1200/JCO.2007.15.2884.CrossRefPubMedPubMedCentral
20.
Bath LE, Critchley HO, Chambers SE, Anderson RA, Kelnar CJ, Wallace WH: Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replacement. Br J Obstet Gynaecol. 1999, 106: 1265-1272. 10.1111/j.1471-0528.1999.tb08180.x.CrossRefPubMed
21.
Bath LE, Wallace WHB, Shaw MP, Fitzpatrick C, Anderson RA: Depletion of ovarian reserve in young women after treatment for cancer in childhood: Detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound. Hum Reprod. 2003, 18: 2368-2374. 10.1093/humrep/deg473.CrossRefPubMed
22.
Lantinga GM, Simons AH, Kamps WA, Postma A: Imminent ovarian failure in childhood cancer survivors. Eur J Cancer. 2006, 42: 1415-1420. 10.1016/j.ejca.2006.01.016.CrossRefPubMed
23.
Larsen EC, Muller J, Rechnitzer C, Schmiegelow K, Andersen AN: Diminished ovarian reserve in female childhood cancer survivors with regular menstrual cycles and basal FSH <10 IU/l. Hum Reprod. 2003, 18: 417-422. 10.1093/humrep/deg073.CrossRefPubMed
24.
Larsen EC, Muller J, Schmiegelow K, Rechnitzer C, Andersen AN: Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab. 2003, 88: 5307-5314. 10.1210/jc.2003-030352.CrossRefPubMed
25.
Lie Fong S, Lugtenburg PJ, Schipper I, Themmen AP, de Jong FH, Sonneveld P, Laven JS: Anti-mullerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies. Hum Reprod. 2008, 23: 674-678. 10.1093/humrep/dem392.CrossRefPubMed
26.
Lie Fong S, Van Den Heuvel-Eibrink M: Pregnancy outcome in female childhood cancer survivors. Molecular Human Reproduction Conference: 25th Annual Meeting of the European Society of Human Reproduction and Embryology, ESHRE. 2009, Amsterdam Netherlands: Conference Publication, i101-Conference Start: 20090628 Conference End: 20090701
27.
Wallace WH, Thomson AB, Saran F, Kelsey TW: Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005, 62: 738-744. 10.1016/j.ijrobp.2004.11.038.CrossRefPubMed
28.
de Boer EJ, Den Tonkelaar I, Burger CW, van Leeuwen FE: Validity of self-reported causes of subfertility. Am J Epidemiol. 2005, 161: 978-986. 10.1093/aje/kwi120.CrossRefPubMed
29.
van Leeuwen FE, Klip H, Mooij TM, van de Swaluw AM, Lambalk CB, Kortman M, Laven JS, Jansen CA, Helmerhorst FM, Cohlen BJ, Willemsen WN, Smeenk JM, Simons AH, van der Veen F, Evers JL, van Dop PA, Macklon NS, Burger CW: Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort. Hum Reprod. 2011, 26: 3456-3465. 10.1093/humrep/der322.CrossRefPubMedPubMedCentral
30.
Hoonakker P, Carayo P: Questionnaire Survey Nonresponse: A Comparison of Postal Mail and Internet Surveys. Int J Hum Comput Interact. 2009, 25: 348-373. 10.1080/10447310902864951.CrossRef
31.
Pealer LN, Weiler RM, Pigg RM, Miller D, Dorman SM: The feasibility of a web-based surveillance system to collect health risk behavior data from college students. Health Educ Behav. 2001, 28: 547-559. 10.1177/109019810102800503.CrossRefPubMed
32.
Vereecken CA, Maes L: Comparison of a computer-administered and paper-and-pencil-administered questionnaire on health and lifestyle behaviors. J Adolesc Health. 2006, 38: 426-432. 10.1016/j.jadohealth.2004.10.010.CrossRefPubMed
33.
van den Berg MH, Overbeek A, van der Pal HJ, Versluys AB, Bresters D, van Leeuwen FE, Lambalk CB, Kaspers GJ, van Dulmen-den Broeder E: Using web-based and paper-based questionnaires for collecting data on fertility issues among female childhood cancer survivors: differences in response characteristics. J Med Internet Res. 2011, 13: e76-10.2196/jmir.1707.CrossRefPubMedPubMedCentral
34.
Coolman M, de Groot CJ, Jaddoe VW, Hofman A, Raat H, Steegers EA: Medical record validation of maternally reported history of preeclampsia. J Clin Epidemiol. 2010, 63: 932-937. 10.1016/j.jclinepi.2009.10.010.CrossRefPubMed
35.
Olson JE, Shu XO, Ross JA, Pendergrass T, Robison LL: Medical record validation of maternally reported birth characteristics and pregnancy-related events: a report from the Children's Cancer Group. Am J Epidemiol. 1997, 145: 58-67. 10.1093/oxfordjournals.aje.a009032.CrossRefPubMed
36.
Rice F, Lewis A, Harold G, van den BM, Boivin J, Hay DF, Owen MJ, Thapar A: Agreement between maternal report and antenatal records for a range of pre and peri-natal factors: the influence of maternal and child characteristics. Early Hum Dev. 2007, 83: 497-504. 10.1016/j.earlhumdev.2006.09.015.CrossRefPubMed
37.
Overbeek A, van den Berg MH, Hukkelhoven CWPM, Malhoe P, Kaspers GJ, Lambalk CB, van Dulmen-den Broeder E, van Leeuwen FE: Validity of self-reported data on pregnancies: a comparison of self-report with data from a nationwide population-based registry. Accepted. (11-10-2012)/ in press Human Reproduction
38.
de Boer EJ, Den Tonkelaar I, te Velde ER, Burger CW, van Leeuwen FE: Increased risk of early menopausal transition and natural menopause after poor response at first IVF treatment. Hum Reprod. 2003, 18: 1544-1552. 10.1093/humrep/deg278.CrossRefPubMed
39.
Jayaprakasan K, Walker KF, Clewes JS, Johnson IR, Raine-Fenning NJ: The interobserver reliability of off-line antral follicle counts made from stored three-dimensional ultrasound data: a comparative study of different measurement techniques. Ultrasound Obstet Gynecol. 2007, 29: 335-341. 10.1002/uog.3913.CrossRefPubMed
40.
Jayaprakasan K, Campbell BK, Clewes JS, Johnson IR, Raine-Fenning NJ: Three-dimensional ultrasound improves the interobserver reliability of antral follicle counts and facilitates increased clinical work flow. Ultrasound Obstet Gynecol. 2008, 31: 439-444. 10.1002/uog.5301.CrossRefPubMed
41.
Merce LT, Gomez B, Engels V, Bau S, Bajo JM: Intraobserver and interobserver reproducibility of ovarian volume, antral follicle count, and vascularity indices obtained with transvaginal 3-dimensional ultrasonography, power Doppler angiography, and the virtual organ computer-aided analysis imaging program. J Ultrasound Med. 2005, 24: 1279-1287.PubMed
42.
Scheffer GJ, Broekmans FJ, Bancsi LF, Habbema JD, Looman CW, te Velde ER: Quantitative transvaginal two- and three-dimensional sonography of the ovaries: reproducibility of antral follicle counts. Ultrasound Obstet Gynecol. 2002, 20: 270-275. 10.1046/j.1469-0705.2002.00787.x.CrossRefPubMed
43.
Ness KK, Leisenring W, Goodman P, Kawashima T, Mertens AC, Oeffinger KC, Armstrong GT, Robison LL: Assessment of selection bias in clinic-based populations of childhood cancer survivors: a report from the childhood cancer survivor study. Pediatr Blood Cancer. 2009, 52: 379-386. 10.1002/pbc.21829.CrossRefPubMedPubMedCentral
Metadata
Title
A nationwide study on reproductive function, ovarian reserve, and risk of premature menopause in female survivors of childhood cancer: design and methodological challenges
Authors
Annelies Overbeek
Marleen H van den Berg
Leontien CM Kremer
Marry M van den Heuvel-Eibrink
Wim JE Tissing
Jacqueline J Loonen
Birgitta Versluys
Dorine Bresters
Gertjan JL Kaspers
Cornelis B Lambalk
Flora E van Leeuwen
Eline van Dulmen-den Broeder
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2012
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-12-363

Other articles of this Issue 1/2012

BMC Cancer 1/2012 Go to the issue

Research article

Biomarkers for antitumor activity of bevacizumab in gastric cancer models

Research article

Cyclin A1 shows age-related expression in benign tonsils, HPV16-dependent overexpression in HNSCC and predicts lower recurrence rate in HNSCC independently of HPV16

Research article

Feasibility of image-guided radiotherapy based on helical tomotherapy to reduce contralateral parotid dose in head and neck cancer

Research article

Survival after chemotherapy and/or radiotherapy versus self-expanding metal stent insertion in the setting of inoperable esophageal cancer: a case-control study

Research article

The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancer

Research article

Phase I study of TP300 in patients with advanced solid tumors with pharmacokinetic, pharmacogenetic and pharmacodynamic analyses
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits